Fluticasone Propionate and Fluticasone Propionate/Salmeterol Compared to FLOVENT® DISKUS® and ADVAIR® DISKUS®

- Asthma
- Completed

Study Title: Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENTֲ® DISKUSֲ® and ADVAIRֲ® DISKUSֲ® in Patients With Persistent Asthma 12 Years of Age and Older

Teva Identifier: FSS-AS-10042

ClinicalTrials.gov Identifier: NCT02437604

Study Status: Completed

Trial Condition(s): Asthma

Interventions: Drug: Treatment A: Fp MDPI | Drug: Treatment B: FS MDPI | Drug: Treatment C Flovent | Drug: Treatment D: Advair

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child, Adult, Older Adult

Age Range: 12 Years and older

Trial Duration: 05/01/2015 - 09/01/2015

Phase: Phase 1

Study Type

Interventional